# Atara Biotherapeutics, Inc.: Form SC 13D/A, filed Sep 5, 2024

- Company: [Atara Biotherapeutics, Inc.](/companies/atra.md) (CIK 1604464)
- Form: SC 13D/A
- Filed: 2024-09-05
- Accepted by EDGAR: Sep 5, 2024, 16:07 ET
- Period: not reported
- Accession: 0001104659-24-097369
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1604464/000110465924097369/tm2423241d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1604464/000110465924097369/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1604464/000110465924097369/tm2423241d1_sc13da.htm

Filed Sep 5, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-097369. Last ingested by Listed: Nov 11, 2026, 02:48 ET. No prices; not investment advice.
